ShareCompartir
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Changes to the National Notifiable Infectious Disease List and Data Presentation --- January 2010
This issue of MMWR incorporates changes to Table I (Provisional cases of infrequently reported notifiable diseases, United States) and Table II (Provisional cases of selected notifiable diseases, United States). This year, the modifications add and remove diseases designated as nationally notifiable by the Council of State and Territorial Epidemiologists (CSTE) in conjunction with CDC (1--5).
Two new diseases have been added to the list of nationally notifiable infectious diseases: viral hemorrhagic fever and dengue fever. Incidence data for viral hemorrhagic fever will appear in Table I, and dengue virus infections will appear in Table II. The surveillance case definitions adopted for these diseases are listed in their respective CSTE position statements (1,2) and are included in the case definitions section of the National Notifiable Diseases Surveillance System (NNDSS) website (3).
Two diseases have been removed from the list of nationally notifiable infectious diseases: invasive group A streptococcal disease and coccidioidomycosis (4,5). Incidence data for these diseases no longer appear in Table II.
Rocky Mountain spotted fever has been renamed spotted fever rickettsiosis (6). Incidence data for spotted fever rickettsiosis continue to appear in Table II.
Streptococcus pneumoniae, invasive disease has replaced two previous nationally notifiable diseases: 1) Streptococcus pneumoniae, nondrug resistant invasive disease in children aged < 5 years and 2) Streptococcus pneumoniae drug-resistant invasive disease (7). Incidence data for Streptococcus pneumoniae, invasive disease appear in Table II.
Data for hepatitis C viral, acute, and ehrlichiosis/anaplasmosis (including subcategories Ehrlichia chaffeensis, Ehrlichia ewingii, Anaplasma phagocytophilum, and ehrlichiosis/anaplasmosis, undetermined) are now displayed in Table II because case reports exceeded 1,000 during 2009.
References
- CDC. Case definitions for infectious conditions under public health surveillance. Available at http://www.cdc.gov/ncphi/disss/nndss/casedef/index.htm. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 09-ID-18. Add viral hemorrhagic fever caused by Ebola or Marburg viruses, Lassa virus, New World Arenaviruses (Guanarito, Machupo, Junin, Sabia), or Crimean-Congo hemorrhagic fever to the nationally notifiable condition list. Available at http://www.cste.org/ps2009/09-id-18.pdf. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 09-ID-19. Add dengue virus infections to the nationally notifiable conditions list. Available at http://www.cste.org/ps2009/09-id-19.pdf. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 09-ID-07. Recommendation to remove invasive group A streptococcus (GAS) from the CSTE list of nationally notifiable diseases. Available at http://www.cste.org/ps2009/09-id-07.pdf. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 07-EC-02. CSTE official list of nationally notifiable conditions. Available at http://www.cste.org/ps/2007ps/2007psfinal/ec/07-ec-02.pdf. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 09-ID-16. Public health reporting and national notification for spotted fever rickettsiosis (including Rocky Mountain spotted fever). Available at http://www.cste.org/ps2009/09-id-16.pdf. Accessed January 11, 2010.
- Council of State and Territorial Epidemiologists. Position statement 09-ID-06. Enhancing state-based surveillance for invasive pneumococcal disease. Available at http://www.cste.org/ps2009/09-id-06.pdf. Accessed January 11, 2010.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
[email protected].
